-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Huiyu Pharmaceuticals according to the imitation of 4 categories of reported yew alcohol injection into the administrative approval stage, is expected to be approved recently and as reviewed.
2019, China's public medical institutions terminal yew alcohol sales of more than 7.5 billion yuan, 2020H1 sales of more than 3.5 billion yuan.
Huiyu Pharmaceuticals will harvest the 4th over-evaluation injection.
Yew alcohol injection is a plant-based anti-tumor drug for ovarian and breast cancer and non-small cell lung cancer (NSCLC) first- and second-line treatment, for head and neck cancer, esophageal cancer, spermogen cell tumor, recurrence of non-Hokin's lymphoma and so on have a certain effect.
meters of intranet data show that in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal yew alcohol sales of more than 7.5 billion yuan, injection of yew alcohol (albumin binding type) accounted for 38.60 percent of the market share, injection of yew alcohol lipids accounted for 38.06 percent, yew alcohol injection accounted for 23.34 percent.
2020H1 China's public medical institutions terminal yew alcohol sales of more than 3.5 billion yuan, an increase of 8.56 percent year-on-year.
Yew alcohol product evaluation enterprise source: Mi net consistency evaluation database is currently listed in the domestic market yew alcohol products include yew alcohol injection, injection of yew alcohol lipids and injection of yew alcohol (albumin binding type).
the injection of yew alcohol lipid body manufacturers only one leaf pharmaceutical, there is no layout consistency evaluation.
injection with yew alcohol (albumin binding type) domestic manufacturers have Stone Pharmaceutical Group, Hengrui Pharmaceuticals, Qilu Pharmaceuticals, Colum Pharmaceuticals and other 4, have been evaluated.
yew alcohol injection manufacturers have 43, the evaluation of enterprises only Yangzijiang Pharmaceutical Group.
Huiyu Pharmaceuticals through / as if through the consistent evaluation of injection sources: Minenet consistency evaluation database as a focus on high-end anti-tumor injection enterprises, Huiyu Pharmaceuticals has three anti-tumor injections have been evaluated, respectively, injection with Pometroxediaze, docetaxel injections, injections with azasides.
huiyu pharmaceutical yew alcohol injection registration status has been changed to "in the approval", if successfully approved will become the second over-evaluation enterprises, harvest paragraph 4 over-evaluation injection.
source: MiNet Database, NMPA